Your shopping cart is currently empty

BRD4 ligand 14 (Compound Y47) is an inhibitor of BRD4. By inhibiting BRD4, BRD4 ligand 14 exhibits mild anticancer properties against acute myeloid leukemia. It acts as a ligand for target proteins (Ligands for Target Protein forPROTAC) and is utilized in the development of PROTAC BRD4 degraders, such as PROTAC BRD4 Degrader-42.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | BRD4 ligand 14 (Compound Y47) is an inhibitor of BRD4. By inhibiting BRD4, BRD4 ligand 14 exhibits mild anticancer properties against acute myeloid leukemia. It acts as a ligand for target proteins (Ligands for Target Protein forPROTAC) and is utilized in the development of PROTAC BRD4 degraders, such as PROTAC BRD4 Degrader-42. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.